Lafaine Grant, M.D.
Associate Professor

Medical School

Wake Forest University School of Medicine (1997)

Internship/Residency

Emory University Hospital (2000), Internal Medicine

Fellowship

Washington University School of Medicine (2004), Gastroenterology

Research Fellowship

Baylor University Medical Center (2007), Hepatology

Liver Transplant Evaluations

• Alcoholic Liver Disease
• Autoimmune Liver Disease
• Drug Induced Liver Injury
• Early Stage Liver Cancer (Hepatocellular Carcinoma or HCC)
• Elevated Transaminase
• End Stage Liver Disease (ESLD)
• Hemochromatosis
• Hepatitis B
• Hepatitis C
• Liver Cirrhosis
• Non-Alcoholic Fatty Liver Disease
• Primary Biliary Cirrhosis (PBC)
• Primary Sclerosing Cholangitis (PSC)

Liver Transplant Medicine

• Immunosuppression
• Liver Transplantation

Liver Disease

• Abnormal Liver Function
• Ascites
• Autoimmune Hepatitis
• Drug Induced Liver Disease
• Fatty Liver
• Liver Cancer, Cysts, Masses & Tumors
• Viral Hepatitis

• Gastroenterology
• Hepatology

Featured Publications

Clinical and Histological Features of Idiosyncratic Acute Liver Injury Caused by Temozolomide.

Grant LM, Kleiner DE, Conjeevaram HS, Vuppalanchi R, Lee WM Dig. Dis. Sci. 2012 Dec

Drug-induced liver injury.

Grant LM, Rockey DC Curr. Opin. Gastroenterol. 2012 May 28 3 198-202

Gastric bypass surgery improves metabolic and hepatic abnormalities associated with nonalcoholic fatty liver disease.

Klein S, Mittendorfer B, Eagon JC, Patterson B, Grant L, Feirt N, Seki E, Brenner D, Korenblat K, McCrea J Gastroenterology 2006 May 130 6 1564-72

Nonalcoholic fatty liver disease.

Grant LM, Lisker-Melman M Ann Hepatol 2004 Jul-Sep 3 3 93-9

Treatment of Hepatitis C Virus in the Liver Transplant Recipient.

Grant L, Crippin JS Curr Treat Options Gastroenterol 2003 Dec 6 6 517-522

• American Association For The Study of Liver Diseases
• American Gastroenterological Association
• American Medical Association